Which Treatment Suits Your Lifestyle And Goals?
Mounjaro and Wegovy Doses: Current UK Stock Availability
The landscape for Mounjaro and Wegovy doses has transformed significantly, with reliable UK supply chains now ensuring consistent availability. Unlike previous years when Wegovy shortages created months-long waiting lists, our partnership with Novo Nordisk ensures all five Wegovy doses remain in stock. From the 0.25mg starter dose through to the 2.4mg maintenance strength, patients can begin their treatment journey immediately without delays.
Mounjaro doses similarly maintain excellent availability through our Eli Lilly supply agreement. Both treatments require identical 4-week dose escalation schedules, meaning your choice between Mounjaro and Wegovy doses should focus on clinical suitability rather than stock concerns. Our clinical assessment system processes applications within 3 working days as standard, with express 24-hour review available for urgent cases requiring immediate treatment commencement.
Mounjaro vs Wegovy Doses: Pricing and Value Comparison
Understanding the financial commitment for Mounjaro and Wegovy doses helps inform your treatment decision. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, while returning patients use DOSE25 to access these final prices.
Our bundle options provide treatment continuity for those progressing through Mounjaro and Wegovy doses. The Intro Duo combines 0.25mg and 0.5mg Wegovy pens for £169.99, covering your first 8 weeks of treatment. For maintenance phases, our Ultimate Stability Trio provides three 2.4mg pens for £649.99, ensuring 3 months of uninterrupted supply without multiple ordering processes.
Clinical Evidence Behind Mounjaro and Wegovy Doses
The STEP trial programme established Wegovy's clinical foundation, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when patients took Wegovy alongside diet and exercise modifications. The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management alone.
Mounjaro's SURMOUNT trials revealed the dual GIP/GLP-1 mechanism's potential, though direct comparisons between Mounjaro and Wegovy doses remain inappropriate due to different trial designs and patient populations. Both treatments require prescription-only medicine status and clinical oversight, with individual responses varying significantly based on adherence, lifestyle factors, and underlying health conditions.
How Wegovy Doses Work in Your Body
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for blood sugar regulation and appetite control. When you inject your weekly Wegovy dose, it activates receptors in your brain's appetite centres, promoting feelings of fullness and reducing food cravings throughout the week. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety after smaller meals. Unlike rapid-acting appetite suppressants, Wegovy's extended-release mechanism provides consistent appetite regulation across all seven days between injections. This mechanism requires alongside implementation of a reduced-calorie diet and increased physical activity to achieve optimal weight management outcomes.
Streamlined Ordering Process for Both Treatment Options
Accessing Mounjaro and Wegovy doses through EverydayMeds follows an efficient three-step pathway designed for convenience and clinical safety. Your journey begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, weight management goals, and previous treatment experiences. Our qualified prescribers review every application thoroughly, with standard processing taking 3 working days or express 24-hour service for urgent requirements. Once approved, your chosen treatment ships via next-day delivery using specialist cold-chain transportation maintaining 2-8°C temperatures throughout transit. All packages include detailed injection technique guides, dose escalation schedules, and 24/7 clinical support contact information for ongoing assistance.
Storage and Practical Considerations for Daily Use
Storage requirements create notable differences between Mounjaro and Wegovy doses that may influence your treatment choice. Wegovy pens maintain stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. This advantage proves particularly valuable for frequent travelers, business professionals, or those with unpredictable schedules requiring flexible storage solutions. Both treatments utilize pre-filled FlexTouch pen systems with hidden needles and automatic injection mechanisms, eliminating traditional syringe preparation complexity. Dose escalation follows identical 4-week intervals for both medications, though individual tolerance levels may necessitate extended periods at lower strengths before progression.
Supply Chain Reliability for Mounjaro and Wegovy Doses in the UK
Our commitment to maintaining consistent Mounjaro and Wegovy doses stems from strategic partnerships with both Novo Nordisk and Eli Lilly, ensuring priority allocation during any potential supply constraints. Historical Wegovy shortages throughout 2022-2023 created patient anxiety about treatment continuity, but our enhanced inventory management now maintains 8-week minimum stock levels across all dose strengths. Temperature-controlled warehouse facilities maintain pharmaceutical-grade storage conditions year-round, while our distribution network covers all UK postcodes with next-day delivery capabilities.
Unlike smaller suppliers who may experience stock-outs during peak demand periods, our volume agreements assurance allocation priority during any market pressures. This reliability means patients can confidently commit to long-term treatment plans without worrying about interruptions that could compromise their weight management progress or require switching between different medications.
Making Your Treatment Decision: Expert Clinical Support
Choosing between Mounjaro and Wegovy doses requires personalized clinical evaluation considering your medical history, lifestyle factors, and individual treatment goals. Our experienced clinical team, operating under GPhC registration #9012878, provides comprehensive consultations helping you understand each option's benefits and considerations. Whether you're drawn to Wegovy's established cardiovascular benefits or interested in Mounjaro's dual-hormone mechanism, professional guidance ensures optimal treatment selection.
Both treatments remain available through our secure ordering system at https://everydaymeds.co.uk/collections/wegovy, with immediate stock availability eliminating previous concerns about treatment delays. Remember to apply discount code FIRST40 for new customers or DOSE25 for returning patients at checkout to access our competitive pricing structure. Start your clinical assessment today and join thousands of patients who've successfully begun their weight management journey through our reliable, professional service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
